| Selected segment financial information |
Selected Segment Financial Information | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | Selected Operating Results Three Months Ended December 31, 2025 | North America | | Europe | | Asia | | South America | | Total | | Net sales – third party | $ | 1,690 | | | $ | 1,159 | | | $ | 556 | | | $ | 670 | | | $ | 4,075 | | | Net sales – intersegment | — | | | 121 | | | 181 | | | 58 | | | 360 | | | Total net sales | $ | 1,690 | | | $ | 1,280 | | | $ | 737 | | | $ | 728 | | | $ | 4,435 | | | | | | | | | | | | | Reconciliation of net sales | | | | | | | | | | Other revenues(1) | | | | | | | | | $ | 111 | | | Elimination of intersegment net sales | | | | | | | | | (360) | | | Consolidated net sales | | | | | | | | | $ | 4,186 | | | | | | | | | | | | | Cost of goods sold (exclusive of metal price lag, depreciation and amortization) | $ | 1,518 | | | $ | 1,146 | | | $ | 646 | | | $ | 569 | | | | | Selling, general and administrative expenses | 65 | | | 48 | | | 26 | | | 27 | | | | Other segment items(2) | 13 | | | 8 | | | 17 | | | 2 | | | | | Adjusted EBITDA | $ | 94 | | | $ | 78 | | | $ | 48 | | | $ | 130 | | | |
_________________________ (1)Other revenues related to amounts to reconcile proportional consolidation of sales attributable to our Logan joint venture partner, Tri-Arrows. As described above, the Logan joint venture is consolidated 100% for U.S. GAAP purposes but managed on a proportionally consolidated basis. (2)Other segment items for all segments are primarily comprised of realized (gain)/loss on derivatives and R&D expense. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | Selected Operating Results Nine Months Ended December 31, 2025 | North America | | Europe | | Asia | | South America | | Total | | Net sales – third party | $ | 5,833 | | | $ | 3,655 | | | $ | 1,923 | | | $ | 1,891 | | | $ | 13,302 | | | Net sales – intersegment | — | | | 125 | | | 532 | | | 147 | | | 804 | | | Total net sales | $ | 5,833 | | | $ | 3,780 | | | $ | 2,455 | | | $ | 2,038 | | | $ | 14,106 | | | | | | | | | | | | | Reconciliation of net sales | | | | | | | | | | Other revenues(1) | | | | | | | | | $ | 345 | | | Elimination of intersegment net sales | | | | | | | | | (804) | | | Consolidated net sales | | | | | | | | | $ | 13,647 | | | | | | | | | | | | | Cost of goods sold (exclusive of metal price lag, depreciation and amortization) | $ | 5,234 | | | $ | 3,399 | | | $ | 2,111 | | | $ | 1,609 | | | | | Selling, general and administrative expenses | 212 | | | 146 | | | 81 | | | 65 | | | | Other segment items(2) | 26 | | | 6 | | | 23 | | | 7 | | | | | Adjusted EBITDA | $ | 361 | | | $ | 229 | | | $ | 240 | | | $ | 357 | | | |
_________________________ (1)Other revenues related to amounts to reconcile proportional consolidation of sales attributable to our Logan joint venture partner, Tri-Arrows. As described above, the Logan joint venture is consolidated 100% for U.S. GAAP purposes but managed on a proportionally consolidated basis. (2)Other segment items for all segments are primarily comprised of realized (gain)/loss on derivatives and R&D expense. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | Selected Operating Results Three Months Ended December 31, 2024 | North America | | Europe | | Asia | | South America | | Total | | Net sales – third party | $ | 1,647 | | | $ | 1,041 | | | $ | 608 | | | $ | 682 | | | $ | 3,978 | | | Net sales – intersegment | — | | | 13 | | | 122 | | | 3 | | | 138 | | | Total net sales | $ | 1,647 | | | $ | 1,054 | | | $ | 730 | | | $ | 685 | | | $ | 4,116 | | | | | | | | | | | | | Reconciliation of net sales | | | | | | | | | | Other revenues(1) | | | | | | | | | $ | 102 | | | Elimination of intersegment net sales | | | | | | | | | (138) | | | Consolidated net sales | | | | | | | | | $ | 4,080 | | | | | | | | | | | | | Cost of goods sold (exclusive of metal price lag, depreciation and amortization) | $ | 1,437 | | | $ | 953 | | | $ | 616 | | | $ | 534 | | | | | Selling, general and administrative expenses | 74 | | | 49 | | | 28 | | | 27 | | | | Other segment items(2) | 14 | | | 3 | | | 11 | | | 3 | | | | | Adjusted EBITDA | $ | 122 | | | $ | 49 | | | $ | 75 | | | $ | 121 | | | |
_________________________ (1)Other revenues related to amounts to reconcile proportional consolidation of sales attributable to our Logan joint venture partner, Tri-Arrows. As described above, the Logan joint venture is consolidated 100% for U.S. GAAP purposes but managed on a proportionally consolidated basis. (2)Other segment items for all segments are primarily comprised of realized (gain)/loss on derivatives and R&D expense. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | Selected Operating Results Nine Months Ended December 31, 2024 | North America | | Europe | | Asia | | South America | | Total | | Net sales – third party | $ | 5,156 | | | $ | 3,315 | | | $ | 1,855 | | | $ | 1,917 | | | $ | 12,243 | | | Net sales – intersegment | 3 | | | 31 | | | 380 | | | 53 | | | 467 | | | Total net sales | $ | 5,159 | | | $ | 3,346 | | | $ | 2,235 | | | $ | 1,970 | | | $ | 12,710 | | | | | | | | | | | | | Reconciliation of net sales | | | | | | | | | | Other revenues(1) | | | | | | | | | $ | 319 | | | Elimination of intersegment net sales | | | | | | | | | (467) | | | Consolidated net sales | | | | | | | | | $ | 12,562 | | | | | | | | | | | | | Cost of goods sold (exclusive of metal price lag, depreciation and amortization) | $ | 4,393 | | | $ | 2,953 | | | $ | 1,870 | | | $ | 1,506 | | | | | Selling, general and administrative expenses | 232 | | | 152 | | | 85 | | | 78 | | | | Other segment items(2) | 44 | | | 39 | | | 22 | | | 11 | | | | | Adjusted EBITDA | $ | 490 | | | $ | 202 | | | $ | 258 | | | $ | 375 | | | |
_________________________ (1)Other revenues related to amounts to reconcile proportional consolidation of sales attributable to our Logan joint venture partner, Tri-Arrows. As described above, the Logan joint venture is consolidated 100% for U.S. GAAP purposes but managed on a proportionally consolidated basis. (2)Other segment items for all segments are primarily comprised of realized (gain)/loss on derivatives and R&D expense. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | | | | | Selected Operating Results Three Months Ended December 31, 2025 | North America | | Europe | | Asia | | South America | | Segment Subtotal | | Eliminations and Other | | Total | | Depreciation and amortization | $ | 66 | | | $ | 45 | | | $ | 25 | | | $ | 23 | | | $ | 159 | | | $ | (4) | | | $ | 155 | | | Income tax provision (benefit) | (87) | | | 14 | | | 4 | | | 23 | | | (46) | | | 50 | | | 4 | | | Capital expenditures | 588 | | | 39 | | | 20 | | | 26 | | | 673 | | | (9) | | | 664 | | | | | | | | | | | | | | | | Selected Operating Results Nine Months Ended December 31, 2025 | | | | | | | | | | | | | | | Depreciation and amortization | $ | 194 | | | $ | 134 | | | $ | 76 | | | $ | 67 | | | $ | 471 | | | $ | (16) | | | $ | 455 | | | Income tax provision (benefit) | (84) | | | 15 | | | 22 | | | 60 | | | 13 | | | 102 | | | 115 | | | Capital expenditures | 1,371 | | | 112 | | | 48 | | | 69 | | | 1,600 | | | (23) | | | 1,577 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | | | | | Selected Operating Results Three Months Ended December 31, 2024 | North America | | Europe | | Asia | | South America | | Segment Subtotal | | Eliminations and Other | | Total | | Depreciation and amortization | $ | 56 | | | $ | 42 | | | $ | 23 | | | $ | 22 | | | $ | 143 | | | $ | (1) | | | $ | 142 | | | Income tax provision (benefit) | (5) | | | 5 | | | 12 | | | 20 | | | 32 | | | 7 | | | 39 | | | Capital expenditures | 366 | | | 54 | | | 27 | | | 18 | | | 465 | | | (7) | | | 458 | | | | | | | | | | | | | | | | Selected Operating Results Nine Months Ended December 31, 2024 | | | | | | | | | | | | | | | Depreciation and amortization | $ | 170 | | | $ | 126 | | | $ | 70 | | | $ | 66 | | | $ | 432 | | | $ | (9) | | | $ | 423 | | | Income tax provision (benefit) | 3 | | | (3) | | | 40 | | | 76 | | | 116 | | | 34 | | | 150 | | | Capital expenditures | 983 | | | 112 | | | 64 | | | 43 | | | 1,202 | | | (27) | | | 1,175 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | in millions | | | | | | | | | | | | | | December 31, 2025 | North America | | Europe | | Asia | | South America | | Segment Subtotal | | Eliminations and Other | | Total | | Investment in and advances to non–consolidated affiliates | $ | — | | | $ | 588 | | | $ | 393 | | | $ | — | | | $ | 981 | | | $ | — | | | $ | 981 | | | Total assets | 8,137 | | | 4,410 | | | 2,022 | | | 2,176 | | | 16,745 | | | 1,501 | | | 18,246 | | | | | | | | | | | | | | | | March 31, 2025 | | | | | | | | | | | | | | | Investment in and advances to non–consolidated affiliates | $ | — | | | $ | 542 | | | $ | 370 | | | $ | — | | | $ | 912 | | | $ | — | | | $ | 912 | | | Total assets | 6,638 | | | 4,303 | | | 2,163 | | | 2,155 | | | 15,259 | | | 1,256 | | | 16,515 | |
The following table displays net sales by product end market: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended December 31, | | Nine Months Ended December 31, | | in millions | 2025 | | 2024 | | 2025 | | 2024 | | Beverage packaging | $ | 2,313 | | | $ | 2,190 | | | $ | 7,336 | | | $ | 6,505 | | | Automotive | 746 | | | 864 | | | 2,782 | | | 2,686 | | | Aerospace and industrial plate | 177 | | | 153 | | | 548 | | | 499 | | | Specialty | 950 | | | 873 | | | 2,981 | | | 2,872 | | | Net sales | $ | 4,186 | | | $ | 4,080 | | | $ | 13,647 | | | $ | 12,562 | |
|
| Reconciliation from income from reportable segments to "Net income attributable to out common shareholder" |
The table below displays the reconciliation from net (loss) income attributable to our common shareholder to Adjusted EBITDA. | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended December 31, | | Nine Months Ended December 31, | | in millions | 2025 | | 2024 | | 2025 | | 2024 | | North America | $ | 94 | | | $ | 122 | | | $ | 361 | | | $ | 490 | | | Europe | 78 | | | 49 | | | 229 | | | 202 | | | Asia | 48 | | | 75 | | | 240 | | | 258 | | | South America | 130 | | | 121 | | | 357 | | | 375 | | | Eliminations and Other | (2) | | | — | | | (1) | | | 4 | | | Adjusted EBITDA | $ | 348 | | | $ | 367 | | | $ | 1,186 | | | $ | 1,329 | | | Depreciation and amortization | (155) | | | (142) | | | (455) | | | (423) | | | Interest expense and amortization of debt issuance costs | (66) | | | (66) | | | (201) | | | (210) | | Adjustment to reconcile proportional consolidation(1) | (12) | | | (9) | | | (39) | | | (34) | | Unrealized (losses) gains on change in fair value of derivative instruments, net | (33) | | | 18 | | | (70) | | | 34 | | Realized gains (losses) on derivative instruments not included in Adjusted EBITDA(2) | 1 | | | (1) | | | 7 | | | (6) | | | | | | | | | | Loss on extinguishment of debt, net | — | | | — | | | (3) | | | — | | | Restructuring and impairment, net | (20) | | | (6) | | | (136) | | | (46) | | Loss on sale or disposal of assets, net | — | | | — | | | (3) | | | (2) | | | | | | | | | | | Metal price lag | 126 | | | — | | | 324 | | | 14 | | Sierre flood losses, net of recoveries(3) | (2) | | | (5) | | | (10) | | | (106) | | September Oswego fire losses, net of recoveries(4) | (300) | | | — | | | (321) | | | — | | November Oswego fire losses, net of recoveries(4) | (27) | | | — | | | (27) | | | — | | Start-up costs(5) | (12) | | | — | | | (25) | | | — | | | Other, net | (3) | | | (7) | | | (12) | | | (11) | | (Loss) income from continuing operations before income tax provision | $ | (155) | | | $ | 149 | | | $ | 215 | | | $ | 539 | | | | | | | | | | | | | | | | | | Income tax provision | (4) | | | (39) | | | (115) | | | (150) | | Net loss attributable to noncontrolling interests | (1) | | | — | | | (1) | | | — | | Net (loss) income attributable to our common shareholder | $ | (160) | | | $ | 110 | | | $ | 99 | | | $ | 389 | |
_________________________ (1)Adjustment to reconcile proportional consolidation relates to depreciation, amortization, and income taxes of our equity method investments. Income taxes related to our equity method investments are reflected in the carrying value of the investment and not in our consolidated income tax provision. (2)Realized gains (losses) on derivative instruments not included in Adjusted EBITDA represents foreign currency derivatives not related to operations. (3)Sierre flood losses, net of recoveries relate to non-recurring non-operating charges from exceptional flooding at our Sierre, Switzerland plant caused by unprecedented heavy rainfall, net of the related property insurance recoveries. See Note 13 – Other Expenses (Income), Net for additional information about this event. (4)September Oswego fire losses, net of recoveries and November Oswego fire losses, net of recoveries relate to non-recurring non-operating charges from two significant fires at our Oswego, New York plant. See Note 13 – Other Expenses (Income), Net for additional information about this event. (5)Start-up costs are related to the construction of a rolling and recycling plant in Bay Minette, Alabama. All of these costs are included in Selling, general and administrative expenses.
|